BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3064600)

  • 1. Neuroendocrine changes in acute myocardial infarction.
    McAlpine HM; Cobbe SM
    Am J Med; 1988 Mar; 84(3A):61-6. PubMed ID: 3064600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine activation after acute myocardial infarction.
    McAlpine HM; Morton JJ; Leckie B; Rumley A; Gillen G; Dargie HJ
    Br Heart J; 1988 Aug; 60(2):117-24. PubMed ID: 3415870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine activation in acute myocardial infarction.
    Dargie HJ; McAlpine HM; Morton JJ
    J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S21-4. PubMed ID: 2441195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction.
    Sigurdsson A; Swedberg K
    Am Heart J; 1996 Jul; 132(1 Pt 2 Su):229-34. PubMed ID: 8677861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine changes in heart failure and their clinical relevance.
    Parmley WW
    Clin Cardiol; 1995 Aug; 18(8):440-5. PubMed ID: 7586761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurohumoral activation and remodeling after acute myocardial infarct and the effect of angiotensin-converting enzyme inhibitors].
    Dúbrava J; Cagán S
    Bratisl Lek Listy; 1993 Feb; 94(2):88-93. PubMed ID: 8102588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment with captopril after acute myocardial infarction.
    Ray SG; Pye M; Oldroyd KG; Christie J; Connelly DT; Northridge DB; Ford I; Morton JJ; Dargie HJ; Cobbe SM
    Br Heart J; 1993 Mar; 69(3):215-22. PubMed ID: 8461219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term neurohormonal activation following acute myocardial infarction.
    Sigurdsson A; Held P; Swedberg K
    Am Heart J; 1993 Nov; 126(5):1068-76. PubMed ID: 8237747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of angiotensin-converting enzyme inhibition on coronary blood flow and infarct size limitation.
    Dargie HJ; Ray SG
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():101-6. PubMed ID: 2674435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
    Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
    Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine activation after acute myocardial infarction.
    Cohn JN
    Am J Cardiol; 1990 May; 65(19):28I-31I. PubMed ID: 2140009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nervous system control mechanisms in heart failure.
    Cohn JN
    Acta Med Scand Suppl; 1986; 707():15-20. PubMed ID: 2874690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of the sympathetic nervous system and of the renin-angiotensin system in the acute stage of myocardial infarction].
    Renard M; Blankoff I; Chami J; Dereppe H; Chi Hoang H; Giot JM; Dramaix M; Bernard R
    Bull Mem Acad R Med Belg; 1991; 146(6-7):305-11. PubMed ID: 1815813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine responses to acute myocardial infarction.
    Levine AB; Levine TB
    Henry Ford Hosp Med J; 1991; 39(3-4):151-4. PubMed ID: 1804818
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs.
    Feng Q; Lu C; Wang L; Song L; Li C; Uppada RC
    BMC Cardiovasc Disord; 2017 Feb; 17(1):65. PubMed ID: 28212603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
    Kleber FX; Nussberger J; Niemöller L; Doering W
    Cardiology; 1992; 81(4-5):213-20. PubMed ID: 1301246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
    Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
    Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.